Teri L Lawver insider trades

Open-market stock purchases and sales by Teri L Lawver, SVP & Chief Commercial Officer at Celldex Therapeutics, Inc, from SEC Form 4 filings since Mar 8, 2023.

Recent trades

DateStockTradeValue
Jun 25, 2026CLDX Celldex Therapeutics, IncBought (not open market)—
May 1, 2026ALT Altimmune, IncBought (not open market)—
Nov 10, 2025CLDX Celldex Therapeutics, IncBought (not open market)—

Companies traded

  • CLDX Celldex Therapeutics, Inc: other filings, last Jun 25, 2026
  • ALT Altimmune, Inc: other filings, last May 1, 2026
  • DXCM DexCom Inc: 1 sale, last Mar 12, 2024

Get free alerts when Teri L Lawver files a new trade →